Trial Profile
A Single Center, Prospective, Non-Randomized, Historical Controlled Trial of dHACM In the Treatment of Diabetic Foot Ulcers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2016
Price :
$35
*
At a glance
- Drugs DHACM (Primary)
- Indications Diabetic foot ulcer
- Focus Adverse reactions; Therapeutic Use
- Sponsors MiMedx
- 25 Jul 2016 Status changed from recruiting to completed.
- 30 Oct 2015 New trial record